Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial
Titel:
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial
Auteur:
Zhang, Panpan Shi, Si Xu, Jianming Chen, Zhendong Song, Lijie Zhang, Xing Cheng, Ying Zhang, Yanqiao Ye, Feng Li, Zhiping Yin, Fei Ji, Dongmei Gao, Heli Li, Yi Chen, Wei Yang, Minjie Weng, Desheng Wu, Chunjiao Ma, Yue Sheng, Wang Zhao, Yaqin Yin, Xiaolei Shen, Weina Su, Weiguo Shi, Michael Fan, Songhua Tan, Panfeng Xu, Qian Lu, Ming Shen, Lin